Wellington Management Group’s Bright Minds Biosciences DRUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11M Buy
221,361
+50,046
+29% +$3.53M ﹤0.01% 1243
2026
Q2
$12M Buy
171,315
+34,638
+25% +$2.72M ﹤0.01% 1242
2026
Q1
$10M Buy
136,677
+122,989
+899% +$9.9M ﹤0.01% 1239
2025
Q4
$1.07M Buy
+13,688
New +$915K ﹤0.01% 1706

Other funds holding DRUG

Wellington Management Group's DRUG Position: Q3 2026 in Review

Wellington Management Group increased its Bright Minds Biosciences (DRUG) stake by 29% in Q3 2026, buying an estimated $3.53M and bringing the position to 221,361 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Wellington Management Group first reported a position in DRUG in Q4 2025 and has held it in 4 quarters since. The position peaked at $12M in Q2 2026. 110 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.

  • Wellington Management Group held 221,361 shares of Bright Minds Biosciences worth $11M as of Q3 2026.
  • Wellington Management Group bought 50,046 Bright Minds Biosciences shares in Q3 2026, an estimated $3.53M.
  • Bright Minds Biosciences made up ﹤0.01% of Wellington Management Group's portfolio in Q3 2026, its #1243 holding.
  • Wellington Management Group first reported a position in Bright Minds Biosciences in Q4 2025 and has held it in 4 quarters since.
  • Wellington Management Group's Bright Minds Biosciences position peaked at $12M in Q2 2026.
  • 110 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.

Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.